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Control of neurotransmitter receptor expression and
delivery to the postsynaptic membrane is of critical im-
portance for neural signal transduction at synapses. The
-aminobutyric acid, type A (GABAA) receptor-associ-
ated protein GABARAP was reported to have an impor-
tant role for movement and sorting of GABAA receptor
molecules to the postsynaptic membrane. GABARAP not
only binds to GABAA receptor 2-subunit but also to
tubulin, gephyrin, and ULK1. We present for the first
time the high resolution structure of human GABARAP
determined by nuclear magnetic resonance in aqueous
solution. One part of the molecule, despite being well
ordered and rigid on a MHz time scale, exists in at least
two different conformations that interchange with each
other on a time scale slower than 25 Hz. An important
feature of the solution structure is the observation that
amino- and carboxyl-terminal ends of the protein di-
rectly interact with each other, which is not seen in
recently reported crystal structures. The possible bio-
logical relevance of these observations for the regula-
tion of GABARAP interactions and functions is
discussed.
Rapid signaling at synapses between neurons are mediated
by small molecules called neurotransmitters. Among neuro-
transmitters, the most prominent are acetylcholine and gluta-
mate for excitatory synapses and glycine and -amino butyric
acid (GABA)1 for inhibitory synapses, respectively. Receptors
for these neurotransmitters are important targets for drugs
used to treat mental disorders or to modulate sleep and mood.
The principal GABA-gated ion channel is the GABA type A
(GABAA) receptor. Drugs that bind to GABAA receptors and
modulate their activity, such as the benzodiazepines, offer both
medical and economic potential.
Control of neurotransmitter receptor expression at the
postsynaptic membrane is of critical importance for functional
neurotransmission. Sorting, targeting, clustering, and degra-
dation of neurotransmitter receptors as dynamic processes play
a key role in the construction and functional maintenance of
synapses.
Recently a novel protein was identified as a binding partner
for the 2-subunit of GABAA receptor, termed GABARAP
(GABAA receptor-associated protein) (1). GABARAP is also re-
ported to bind tubulin (1), gephyrin (2), and ULK1 (3). It is
closely related to light chain-3 (LC-3) of microtubule-associated
proteins 1A and 1B (MAP-1A and -1B) and to the “late acting
intra-Golgi transport factor,” termed GATE-16, of which crys-
tal structures are known (4). In contrast to GABARAP, how-
ever, GATE-16 does not interact with gephyrin and GABAA
receptor 2-subunit (2). GABARAP is postulated to have an
important role for early steps in movement and sorting of
GABAA receptors (5) and for GABAA receptor clustering at the
postsynaptic membrane. Binding affinity of GABA to GABAA
receptors as well as kinetics of inactivation and desensitization
of the receptors are dependent on the clustering state of the
GABA receptor, which was reported to be strongly modulated
by GABARAP (6). Modulation of GABARAP binding to its
interaction partners provides a new avenue for pharmacologi-
cal intervention of receptor activity and neurotransmitter ac-
tion at the synapse. We and others therefore started a detailed
structural investigation of GABARAP. The first available crys-
tal structure of GABARAP (7) turned out to be very similar to
the crystal structures of GATE-16 (4), which is not very sur-
prising since sequence identity between both proteins is 57%.
GATE-16 and the GABARAP crystal structures resemble ubiq-
uitin folds with two additional amino-terminal helices. A dif-
ference in GATE-16 in the putatively flexible carboxyl-terminal
residues and smaller differences in helix 2 and loop regions
were found. An additional two different crystal structures of
GABARAP are reported but not deposited in the Protein Data
Bank (8) rendering them impossible to be studied in detail and
compared with other structures. Coyle et al. (8) obtained the
structures from two different crystal forms. One structure is
reported to resemble closely that of GATE-16. The other crystal
form was obtained under high salt conditions in which helix 1
is flipped by180°, pointing away from the rest of the molecule
and contacting the neighboring molecule in the crystal in a
head to tail fashion. Whether this polymerized state of
GABARAP might be of physiological relevance is not clear.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—GABARAP was expressed and
purified as a glutathione S-transferase fusion protein. Thrombin
(Merck) cleavage was performed yielding full-length GABARAP with
additional glycine and serine residues at its amino terminus. Details of
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cloning, protein expression, and purification of GABARAP have been
described elsewhere (9).
NMR Spectroscopy—NMR samples contained 0.8 mM protein in 25
mM sodium phosphate, 100 mM NaCl, 100 mM KCl, pH 6.9, in 95% H2O,
5% D2O with 100 M phenylmethylsulfonyl fluoride, 0.02% (by weight)
sodium azide, and 50 M EDTA. NMR spectra were recorded at 298 K
on a Varian Unity INOVA spectrometer equipped with a triple-axis
pulse-field gradient 1H/15N/13C probe at proton frequencies of 600 and
750 MHz. The resonance assignment of GABARAP was described pre-
viously (9). Structural constraints were derived from 15N-edited
NOESY-HSQC (100-ms mixing time) (10), aliphatic 13C-edited NOESY-
HSQC (80-ms) experiments (11) in the described buffer, and aliphatic
13C-edited NOESY-HSQC (120-ms) and aromatic 13C-edited NOESY-
HSQC (120-ms) experiments with protein in the buffer after replace-
ment of H2O by D2O. Uniformly
13C-15N-labeled protein was used for
these experiments. 15N-Labeled protein was used for the 1H-15N het-
eronuclear NOE experiments (12).
Data Evaluation and Structure Calculation—Based on the almost
complete assignment of 1H, 13C, and 15N resonances of GABARAP, a
total of 4577 NOE distance constraints (including 1375 long range
NOEs) could be derived from three-dimensional NOESY spectra in an
iterative procedure (Table I). NOE analysis and assignment were per-
formed using NMRView (13) and ARIA (14). Interproton distances were
used directly to calibrate experimental peaks and to extract distance
constraints. Lower and upper bounds for distance constraints were
derived from the target distances empirically by estimation of the error
as 12.5% of the target distance squared. Distances involving ambiguous
constraints, methyl groups, aromatic ring protons, and the nonste-
reospecifically assigned methylene protons were treated as sum of
separate contributions to the target function, known as “sum averag-
ing” (15).
Final structures were calculated using the simulated annealing pro-
tocol with the program CNS version 1.0 (16) using standard parameters
with the following modifications. For conformational space sampling 20
ps with a time step of 10 fs were simulated using torsion angle dynamics
at a temperature of 50,000 K followed by 30 ps of slow cooling to 0 K
with a time step of 15 fs. In an additional Cartesian slow cooling stage,
the temperature was decreased in 20 ps from 2000 to 0 K with a time
step of 5 fs. After simulated annealing the structures were subjected to
2000 steps of energy minimization.
A total of 15 structures that did not show any distance constraint
violation of more than 0.0175 nm was used for further analysis. Geom-
etry of the structures, structural parameters, and secondary structure
elements were analyzed and visualized using the programs MOLMOL
(17), PROCHECK (18), and WHATIF (19). The coordinates have been
deposited in the Protein Data Bank with accession code 1KOT.
RESULTS AND DISCUSSION
Solution Structure and Comparison with Crystal Structures
of GABARAP and GATE-16—Earlier we reported almost com-
plete assignments for backbone and side chain 1H, 13C, and 15N
resonances of human GABARAP (9). Simultaneously backbone
resonance assignments were reported by others (20). Reinspec-
tion of the spectra allowed us to increase especially the extent
of backbone 1H and 15N amide resonance assignments to 98%.
Only amide resonances of Val6 and Asp102 eluded their
assignment.
A total of 4577 NOE distance constraints, including 1375 long
range NOEs (Table I), derived from three-dimensional 15N- or
13C-edited NOESY spectra recorded from uniformly 15N and 13C
isotope-labeled recombinantly expressed GABARAP protein was
taken as input for simulated annealing and refinement calcula-
tions. No other constraints were used. Together 15 structures
were obtained that did not show any NOE distance violation
greater than 0.0175 nm. The root mean square deviation of these
15 structures relative to their average structure was 0.049 and
0.105 nm for backbone and all heavy atoms, respectively. That
means the resulting structure is rather well defined as seen in
the overlay of all 15 protein backbones (Fig. 1A).
The structure of GABARAP exhibits a compact fold consist-
ing of a four-stranded -sheet with two -helices on either side
(Fig. 1B). Similar to the ubiquitin fold, the outer strands of the
FIG. 1. Solution structure of human GABARAP after simulated annealing and refinement calculations. A, shown is the superposition
of the backbones of all 15 obtained structures. B, ribbon presentation of the averaged GABARAP structure. Secondary structure elements are
labeled according to their sequential arrangement. Amino- (N) and carboxyl (C)-terminal ends are indicated. C, backbone worm presentation of
GABARAP. Residues that contain amide groups with split or broadened resonance peaks are colored in red. Residues Val6 and Asp102 are also
colored in red because their amide resonances were undetectable. This indicates that the respective residues are involved in conformational
exchange on a slow to intermediate time scale. Prominent residues are labeled with amino acid type and sequence position. All figures were
prepared using MOLMOL (17).
TABLE I
Constraints and structural statistics for the resulting 15 NMR
structures of GABARAP
Number of experimental restraints
Total number of assigned NOEs 4577
Intraresidue (i  j  0) 1448
Interresidue sequential (i  j  1) 885
Interresidue medium range (1  i
 j  5)
869
Long range (i  j  5) 1375
CNS energies (kcal/mol)
Total 259.19  5.91
Bond 12.08  0.53
Angle 95.04  2.76
Impropers 12.85  0.79
van der Waals 99.55  3.58
NOE 39.68  2.17
r.m.s.d. to the mean structure (nm)
Backbone heavy atoms 0.049  0.017
All heavy atoms 0.105  0.014
r.m.s.d. to experimental constraints
and idealized geometry
NOE (nm) 0.00097  0.00002
Bond (nm) 0.00024  0.00001
Angle (°) 0.4126  0.0060
Impropers (°) 0.2791  0.0086
,  angles consistent with
Ramachandran plot (%)
Most favored regions 72.6
Allowed regions 96.8
Generously allowed regions 98.4
GABARAP Solution Structure13364
 at R









-sheet are aligned antiparallel to the inner strands, which are
parallel to each other, and helices 3 and 4 are located on one
side of the sheet. In addition to the ubiquitin fold, GABARAP
contains two additional helices, 1 and 2, that are located on
the opposite side of the -sheet relative to 3 and 4.
Average local displacement values relative to the mean
structure are a measure for the precision of the derived family
of structures. Large values indicate either local flexibility of the
protein or lack of experimental data for this region. Average
local displacement values of the GABARAP solution structure
indicate the regions Asp45–Lys47, Leu70–Glu73, and Glu101–
Leu105 of the protein to be less defined (Fig. 2A). The first two
regions also have slightly decreased heteronuclear NOE values
(Fig. 2B) indicating increased dynamic behavior. 1H-15N het-
eronuclear amide NOE values are a measure for the dynamics
of the local environment within the time scale of the absolute
NMR frequencies (60–750 MHz in the present study).
Overall the solution structure is very similar to that of the
GABARAP crystal structure (7). Notable differences between
the solution structure and all deposited crystal structures of
GABARAP and GATE-16 map to residues 2–14, 37–46, 66–75,
and 113–117. The first region largely overlaps with residues
that appear in the NMR spectra as broadened and split reso-
nances. Regions 37–46 and 66–75 coincide with those shown to
have slightly increased mobility as inferred from heteronuclear
NOE data (Fig. 2B).
The root mean square deviation (r.m.s.d.) value for the back-
bone coordinates of residues 1–112 is 0.134 nm between
GABARAP solution and crystal structure (7) as well as 0.139
and 0.151 nm for GABARAP solution structure and GATE-16
crystal structures (4). The coordinates for the very carboxyl-
terminal residues, however, differ remarkably.
Some Regions of GABARAP Are Involved in Conformational
Exchange—Backbone amide resonances of a number of resi-
dues showed up in the NMR spectra as broadened and split
lines, indicating conformational exchange on an intermediate
and slow time scale. Due to the lack of concentration depend-
ence, the observed phenomenon could not be assigned to a
monomer-dimer equilibrium. The respective residues map to
completely different sequence regions (Val4–Lys20 without
Glu12 and Ser16, His99–Leu105 without Phe103, and Lys47) that
are all close to each other in space (Fig. 1C). The first region
encompasses helix 1 and a large portion of helix 2, and the
second region belongs to the loop between helix 4 and strand
4. The carboxyl-terminal Leu105 of the second region exhibits
a split backbone amide resonance, but the corresponding pro-
ton is involved in stable -sheet-like secondary structure hy-
drogen bonding with the Pro30 backbone carbonyl oxygen as
suggested by inspection of the structure and the stability of the
Leu105 amide proton in hydrogen exchange experiments (data
not shown). Lys47 is located next to the amino terminus of
strand 2, and its side chain protrudes to the amino terminus
of helix 1, thus obviously opposing the dipole of helix 1.
Phe103, Glu12, and Ser16 appear not to be affected by line
broadening or splitting. Also the amino-terminal residues
Met1, Lys2, and Phe3 are not visibly affected by conformational
exchange phenomena. To estimate the time scale for a potential
exchange between the different conformations corresponding to
the different observed sets of resonances, the frequency dis-
tance for several pairs of split amide resonances were meas-
ured. Some of them (Arg15 and Lys20) yielded values of 25 and
27 Hz, respectively. That leads to the conclusion that, under
the conditions used in the present study, any exchange between
the conformers is slower than 25 Hz.
Interestingly all residues involved in this conformational
exchange are spatially close to Pro10. This residue is discussed
as the hinge for the interchange between two different confor-
mations yielded for GABARAP under different crystallization
conditions (8). Comparing both conformations relative to each
other, helix 1 is flipped by 180° at residue Pro10. The poten-
tial of conformational changes around Pro10 is principally in
accordance with the dynamics observations obtained for the
GABARAP solution structure. However, the proposed head to
tail polymerization could not be observed under the conditions
used in the present study.
The Carboxyl-terminal Part of GABARAP Is Well Defined
and in Direct Contact with the Amino-terminal Residues—
FIG. 3. Focused view of the GABARAP structure. Shown is the
superposition of the backbone atom connections of residues Met1, Lys2,
Ala36, Pro37, Ala108, and Tyr115–Leu117 (all in black) for all obtained
structures. The side chains of Met1, Ala36, Pro37, Ala108, and Leu117
(gray) form a hydrophobic pocket for the side chain of Tyr115 (blue). The
hydroxyl oxygen of the Tyr115 phenolic ring is hydrogen-bonded to the
backbone amide nitrogen of Lys2 (red).
FIG. 2. Precision of local conformation, dynamic behavior, and
number of distance constraints per residue. A, average local dis-
placement values among the 15 obtained solution structures. For each
three-residue window the average displacement of the backbone atoms
was calculated and plotted against the residue number that corre-
sponds to the central residue of the window. B, heteronuclear 1H-15N
NOE values of amide resonances. C, number of intraresidual (black),
sequential (light gray), medium (dark gray), and long range (white)
NOE distance constraints per residue.
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GABARAP and GATE-16 crystal structures indicate that the
carboxyl-terminal part of the respective molecule is not an
integral part of the protein scaffold. In the publicly accessible
crystal structures of GABARAP and the two GATE-16 conform-
ers the carboxyl termini differ significantly among themselves
and compared with the solution structure. This may be due to
different favorable crystal contacts of the carboxyl-terminal
end observed in the crystal structures (4, 7). Inspection of the
solution structure of GABARAP reveals that the hydroxyl ox-
ygen of the Tyr115 phenolic ring is hydrogen-bonded to the
backbone amide nitrogen of Lys2 (Fig. 3). Furthermore Tyr115
is involved in a network of hydrophobic interactions. The
methyl groups of Met1, Ala36, Ala108, and Leu117, as well as the
side chain of Pro37, form a hydrophobic pocket for Tyr115 as
evidenced by a large number of direct NOE observations be-
tween these residues. In addition to Tyr115 and Leu117, most of
the carboxyl-terminal residues are involved in numerous direct
NOE-observable contacts to residues of the amino terminus
and the loop connecting -strands 1 and 2. Thus, clearly the
carboxyl-terminal residues of GABARAP are an integral part of
the globular and compact structure of GABARAP.
Throughout the GABARAP and GATE-16 family of proteins,
Phe115 appears to be highly conserved (4). GABARAP itself and
a Caenorhabditis elegans ortholog of GATE-16 are the only
remarkable exceptions, containing a tyrosine at this position.
Stabilizing the closed conformation of the carboxyl terminus in
the GABARAP solution structure using a hydrogen bond in
addition to hydrophobic interactions might therefore be a
unique feature of GABARAP that is, however, not observed in
the reported crystal structure. 1H-15N NOE data confirm that
Tyr115 does not exhibit a decreased heteronuclear NOE (Fig.
2B) as would be expected for a residue not rigidly connected to
the globular fold of the protein.
The carboxyl terminus of GABARAP may play a decisive role
in the biological function of the protein. GABARAP as well as
GATE-16, MAP-LC-3, and human Apg12p were shown to be
substrates for human Apg7p, a novel E1 enzyme essential for
the Apg12p-conjugating system (21), a system involved in au-
tophagy. Autophagy is a process that involves the bulk degra-
dation of cytoplasmic components by the lysosomal/vacuolar
system, which is conserved from yeast to mammalian cells. For
the yeast system, it was shown that Apg12p is covalently
attached to Apg5p via the carboxyl-terminal glycine residue of
Apg12p, which is very similar to the ubiquitin system (22).
Apg12p is a homologue to GATE-16 and GABARAP. If indeed
GABARAP plays a role in these kinds of covalent modification
systems, its carboxyl terminus needs to be accessible during
this process.
The two conformations found for GATE-16 were discussed
already in regard to a potential role of the carboxyl terminus as
a regulating element for modulating binding events (4). Trans-
ferred to GABARAP, this could mean that the solution struc-
ture of GABARAP resembles the conformation of free and un-
liganded GABARAP. The crystal structure of GABARAP may
indicate the existence of a second conformation with its car-
boxyl terminus detached from the major part of the protein
with an increased accessibility for the carboxyl-terminal
residues.
Taking all observations together, it seems that the amino-
terminal part of GABARAP exists in a state that allows at least
two different conformations. Any decision between either one of
them, e.g. upon tubulin binding, may influence subsequently
the orientation of the closely attached carboxyl-terminal region
of the protein. Its different orientations in the structures
reported so far strongly suggest that this part of GABARAP
is able to exist in various orientations relative to the rest of
the protein. Such a direct conformational communication be-
tween a potentially interaction-sensitive region (residues high-
lighted in Fig. 1C) with a distant region of the protein is,
however, a speculation that needs to be addressed by future
investigations.
This kind of triggered conformational change may also be
used for rational manipulation of GABARAP function. Selec-
tive stabilization of the conformation with a tightly attached
carboxyl terminus may inhibit binding to interaction partners.
Acknowledgment—We thank C. Beck for technical assistance.
REFERENCES
1. Wang, H., Bedford, F. K., Brandon, N. J., Moss, S. J., and Olsen, R. W. (1999)
Nature 397, 69–72
2. Kneussel, M., Haverkamp, S., Fuhrmann, J. C., Wang, H., Wassle, H., Olsen,
R. W., and Betz, H. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 8594–8599
3. Okazaki, N., Yan, J., Yuasa, S., Ueno, T., Kominami, E., Masuho, Y., Koga, H.,
and Muramatsu, M. (2000) Brain Res. 85, 1–12
4. Paz, Y., Elazar, Z., and Fass, D. (2000) J. Biol. Chem. 275, 25445–25450
5. Kneussel, M., and Betz, H. (2000) Trends Neurosci. 23, 429–435
6. Chen, L., Wang, H., Vicini, S., and Olsen, R. W. (2000) Proc. Natl. Acad. Sci.
U. S. A. 97, 11557–11562
7. Knight, D., Harris, R., McAllister, M. S. B., Phelan, J. P., Geddes, S., Moss,
S. J., Driscoll, P. C., and Keep, N. H. (2002) J. Biol. Chem. 277, 5556–5561
8. Coyle, J. E., Qamar, S., Rajeshankar, K. R., and Nikolov, D. B. (2002) Neuron
33, 63–74
9. Stangler, T., Mayr, L. M., Dingley, A. J., Luge, C., and Willbold, D. (2001)
J. Biomol. NMR 21, 183–184
10. Zuiderweg, E. R., and Fesik, S. W. (1989) Biochemistry 28, 2387–2391
11. Muhandiram, D. R., Farrow, N. A., Xu, G.-Y., Smallcombe, S. H., and Kay,
L. E. (1993) J. Magn. Res. 102B, 317–321
12. Farrow, N. A., Muhandiram, R., Singer, A. U., Pascal, S. M., Kay, C. M., Gish,
G., Shoelson, S. E., Pawson, T., Forman-Kay, J. D., and Kay, L. E. (1994)
Biochemistry 33, 5984–6003
13. Johnson, B. A., and Blevins, R. A. (1994) J. Biomol. NMR 4, 603–614
14. Nilges, M., and O’Donoghue, S. I. (1998) Prog. NMR 32, 107–139
15. Nilges, M. (1993) Proteins 17, 297–309
16. Bru¨nger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-
Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read,
R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr.
Sect. D Biol. Crystallogr. 54, 905–921
17. Koradi, R., Billeter, M., and Wu¨thrich, K. (1996) J. Mol. Graph. 14, 51–55
18. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993)
J. Appl. Crystallogr. 26, 283–291
19. Vriend, G. (1990) J. Mol. Graph. 8, 52–56
20. Harris, R., McAllister, M. S. B., Sankar, A., Phelan, J. P., Moss, S. J., Keep,
N. H., and Driscoll, P. C. (2001) J. Biomol. NMR 21, 185–186
21. Tanida, I., Tanida-Miyake, E., Ueno, T., and Kominami, E. (2001) J. Biol.
Chem. 276, 1701–1706
22. Mizushima, N., Noda, T., Yoshimori, T., Tanaka, Y., Ishii, T., George, M. D.,
Klionsky, D. J., Ohsumi, M., and Ohsumi, Y. (1998) Nature 395, 395–398
GABARAP Solution Structure13366
 at R
sch Cntr Julich Res library on August 6, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
